CMV pneumonitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{CMG}} {{CMV pneumonitis}} ==Overview== === Pharmacotherapy === * Treatment is most commonly with ganciclovir 5 mg/kg q12h, though results are disappointing. BMT patients ..." |
Esther Lee (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | {{CMG}} | ||
{{CMV pneumonitis}} | {{CMV pneumonitis}} | ||
| Line 4: | Line 5: | ||
==Overview== | ==Overview== | ||
== | ==Medical Therapy== | ||
* Treatment is most commonly with ganciclovir 5 mg/kg q12h, though results are disappointing. BMT patients characteristically respond, but clinical response is quite variable in AIDS patients, inconsistently showing a significant benefit in different studies. | *Treatment is most commonly with ganciclovir 5 mg/kg q12h, though results are disappointing. BMT patients characteristically respond, but clinical response is quite variable in AIDS patients, inconsistently showing a significant benefit in different studies. | ||
*Prophylaxis is now being used at some transplant centers. Options include CMV hyperimmune globulin or antiviral treatment such as ganciclovir. | |||
== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Disease]] | |||
{{ | [[Category:Immunology]] | ||
[[Category:Pulmonology]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 18:37, 25 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
CMV pneumonitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
CMV pneumonitis medical therapy On the Web |
|
American Roentgen Ray Society Images of CMV pneumonitis medical therapy |
|
Risk calculators and risk factors for CMV pneumonitis medical therapy |
Overview
Medical Therapy
- Treatment is most commonly with ganciclovir 5 mg/kg q12h, though results are disappointing. BMT patients characteristically respond, but clinical response is quite variable in AIDS patients, inconsistently showing a significant benefit in different studies.
- Prophylaxis is now being used at some transplant centers. Options include CMV hyperimmune globulin or antiviral treatment such as ganciclovir.